PMID- 23681157 OWN - NLM STAT- MEDLINE DCOM- 20140331 LR - 20211021 IS - 1432-2072 (Electronic) IS - 0033-3158 (Print) IS - 0033-3158 (Linking) VI - 229 IP - 2 DP - 2013 Sep TI - Fostering itself increases nicotine self-administration in young adult male rats. PG - 227-34 LID - 10.1007/s00213-013-3093-x [doi] AB - RATIONALE: In gestational exposure studies, a fostered group is frequently used to control for drug-induced maternal effects. However, fostering itself has varying effects depending on the parameters under investigation OBJECTIVES: This study was designed to assess whether maternal behavior contributed to enhanced acquisition (higher number of bar presses compared to controls) of nicotine self-administration (SA) displayed by offspring with gestational nicotine and ethanol (Nic+EtOH) exposure. METHODS: Offspring were exposed to Nic+EtOH throughout full gestation, that is, gestational days (GD) GD2-20 and during postnatal days 2-12 (PN2-12), the rodent third trimester equivalent of human gestation during which rapid brain growth and synaptogenesis occur. Young adult (PN60) male offspring acquired operant nicotine SA, using a model of unlimited (i.e., 23 h) access to nicotine. RESULTS: Gestational drug treatments did not alter litter parameters (body weight, volume distribution, crown-rump length, and brain weight) or postnatal growth of the offspring. Fostering increased locomotor activity to a novel environment on PN45 regardless of gestational treatment group. Surprisingly, fostering per se significantly increased the SA behavior of drug-naive pair-fed controls, so that their drug-taking behavior resembled the enhanced nicotine SA observed in non-fostered offspring exposed to Nic+EtOH during gestation. In contrast, fostering did not change the SA behavior of the Nic+EtOH group. CONCLUSIONS: Fostering is shown to be its own experimental variable, ultimately increasing the acquisition of nicotine SA in control, drug-naive offspring. As such, the current dogma that fostering is required for our gestationally drug-exposed offspring is contraindicated. FAU - Roguski, Emily E AU - Roguski EE AD - Department of Pharmacology, University of Tennessee Health Science Center, 115 Crowe Research Building, 874 Union Ave., Memphis, TN 38163, USA. eroguski@uthsc.edu FAU - Chen, Hao AU - Chen H FAU - Sharp, Burt M AU - Sharp BM FAU - Matta, Shannon G AU - Matta SG LA - eng GR - R01 DA015525/DA/NIDA NIH HHS/United States GR - DA015525/DA/NIDA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20130517 PL - Germany TA - Psychopharmacology (Berl) JT - Psychopharmacology JID - 7608025 RN - 0 (Central Nervous System Depressants) RN - 0 (Nicotinic Agonists) RN - 3K9958V90M (Ethanol) RN - 6M3C89ZY6R (Nicotine) SB - IM MH - Age Factors MH - Analysis of Variance MH - Animals MH - Animals, Newborn MH - Central Nervous System Depressants/*adverse effects MH - Ethanol/*adverse effects MH - Female MH - *Foster Home Care MH - Male MH - Motor Activity/drug effects MH - Nicotine/administration & dosage/adverse effects MH - Nicotinic Agonists/*administration & dosage/adverse effects MH - Pregnancy MH - Prenatal Exposure Delayed Effects/*chemically induced MH - Rats MH - Rats, Sprague-Dawley MH - Self Administration PMC - PMC3757107 MID - NIHMS481608 EDAT- 2013/05/18 06:00 MHDA- 2014/04/01 06:00 PMCR- 2014/09/01 CRDT- 2013/05/18 06:00 PHST- 2012/03/16 00:00 [received] PHST- 2013/03/29 00:00 [accepted] PHST- 2013/05/18 06:00 [entrez] PHST- 2013/05/18 06:00 [pubmed] PHST- 2014/04/01 06:00 [medline] PHST- 2014/09/01 00:00 [pmc-release] AID - 10.1007/s00213-013-3093-x [doi] PST - ppublish SO - Psychopharmacology (Berl). 2013 Sep;229(2):227-34. doi: 10.1007/s00213-013-3093-x. Epub 2013 May 17.